Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Journal of Neuro-Oncology|November 30, 2005
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology groupMurali M Chintagumpala, Henry S Friedman, Clinton F Stewart, et al.Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.The Lancet. Respiratory Medicine|July 24, 2021
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trialKlaus F Rabe, Bartolome R Celli, Michael E Wechsler, et al.Scientific Reports|March 11, 2021
Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's DiseaseJulie E Horowitz, Neil Warner, Jeffrey Staples, et al.Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.Science Translational Medicine|October 29, 2025
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthmaSeblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, et al.Critical Care Explorations|November 13, 2023
Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From SepsisPatrick R Lawler, Garen Manvelian, Alida Coppi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 26, 2022
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical TrialSumathi Sivapalasingam, David J Lederer, Rafia Bhore, et al.Pageof 13